Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Two senior Federal Reserve officials signaled on Tuesday that they do not see a pressing need to alter the current stance of interest-rate policy in the near term. While markets anticipate further rate cuts later this year, officials said they need clearer evidence that inflation pressures are returning to the Fed's 2% goal before moving. Both note…
Mexican authorities say Nemesio Oseguera, known as El Mencho and leader of the Jalisco New Generation Cartel (CJNG), spent his last hours in a two-storey villa inside the gated Tapalpa Country Club. Photographs and on-site observations describe a home with modern finishes, a cluttered kitchen, numerous medications, religious icons and signs of a mi…
A full panel of the U.S. Court of Appeals for the D.C. Circuit questioned the Trump administration’s contention that federal courts lack authority to prevent large-scale dismissals of staff at the Consumer Financial Protection Bureau (CFPB). The CFPB has been largely inactive since last February while the administration pursues court approval to dr…
Raymond James reduced its price target on Fidelity National Information Services to $60 from $82 while keeping an Outperform rating after the payments processor reported fourth-quarter results with slight revenue beats but a small EPS miss tied to weaker adjusted EBITDA margins. Management provided initial fiscal 2026 guidance for the combined busi…
The New York Police Department has opened an investigation into a large snowball fight in Washington Square Park after footage showed officers being hit in the face. Police Commissioner Jessica Tisch characterized the actions as criminal assaults on uniformed officers, while Mayor Zohran Mamdani described the scene as children behaving disrespectfu…
Adam David Sachs, president of Vicarious Surgical Inc. (NASDAQ: RBOT), sold 942 shares of Class A common stock on February 20, 2026, for $1,966 to meet tax-withholding obligations tied to vested restricted stock units. The sale occurred at a weighted average price of $2.0878, with prices ranging from $1.845 to $2.290. Following the transaction, Sac…
Texas Capital Securities began coverage of Angel Studios Inc. (NYSE: ANGX) with a Buy rating and a $6.50 price target, implying almost 100% upside from the current $3.26 share price. The firm highlighted the company's creator-focused business model, membership expansion and recent box office success, while noting the near-term need for external cap…
Mizuho upgraded Neptune Insurance Holdings (NYSE: NP) to Neutral from Underperform and trimmed its price target to $24 from $26, saying the firm sees artificial intelligence as unlikely to disrupt Neptune's business. The bank raised near-term earnings estimates even as it pointed to low free cash flow yield and potential private flood market compet…
Equities moved higher on Tuesday as investors appeared to reassess recent AI-driven selling, while a surprise adjustment to U.S. tariff policy and anticipation of Nvidia's quarterly results added to market momentum. Strength in Asian markets and semiconductors contrasted with weakness in Treasuries at the short end and declines in commodities.
MercadoLibre reported a quarterly net income decline that missed analyst forecasts, as higher investments in credit issuance, free shipping and direct sales compressed margins. Revenue outpaced estimates, supported by strong growth in Brazil and Mexico. Operating profits rose modestly while margins narrowed, and the company said Venezuela remains i…
Netflix looks set for another material re-acceleration driven by ad-tier monetization, international price normalization and a stronger content cadence. I’m upgrading the rating to Buy and laying out an entry at $450, a $650 target and a $395 stop-loss for a long-term trade (180 trading days).
RBC Capital initiated coverage of Merck & Co. (MRK) with an outperform rating and a $142.00 price target. The firm pointed to shifting sentiment as Merck moves beyond Gardasil-related worries and greater visibility into its pipeline, notably the oral PCSK9 and CADENCE programs. RBC expects investor enthusiasm to build over the next 12 to 18 months …
Stifel has begun coverage of Palisade Bio Inc. (PALI) with a Buy rating and a $5.00 target, highlighting the companys PALI-2108 as a potentially orthogonal oral PDE4 pro-drug for inflammatory bowel disease. The stock trades at $1.79 with a market capitalization of $267 million and has posted strong recent returns. Early clinical data and external …
RBC Capital has commenced coverage of AbbVie Inc. (NYSE: ABBV) with an outperform rating and a $260.00 price objective, arguing the market underestimates the company’s growth durability and cash-generation profile. The firm disagrees with views that AbbVie’s beat-and-raise momentum has ended and that competition will sharply erode its immunology fr…
RBC Capital began coverage of Eli Lilly with an outperform rating and a $1,250 price target, citing the drugmaker's dominant obesity franchise through 2030, patent protection into the mid-2030s, manufacturing advantages and meaningful pipeline opportunities. The firm says consensus estimates underappreciate catalysts such as a Medicare agreement, o…
RBC Capital has initiated coverage of Bristol-Myers Squibb Co. (BMY) with a Sector Perform rating and a $60 price objective, saying current valuation reflects market re-rating rather than reduced fundamental risk. The stock is trading above that target amid a six-month rally, while RBC highlights a sizeable Phase 3 pipeline and cautions that sustai…
RBC Capital has initiated coverage of Pfizer with an Underperform rating and a $25.00 price target, below the stock's recent trading level. The firm highlights an anticipated $15 billion to $20 billion revenue decline through 2030, limited pipeline visibility until at least 2028, and structural headwinds that a high dividend yield cannot fully coun…
Oppenheimer has begun covering BioAge Labs Inc (BIOA) with an Outperform rating and a $60 price target, citing confidence in the company’s lead candidate BGE-102, an oral NLRP3 inhibitor. The stock trades at $21.56 after a 391% gain over the last year per InvestingPro data. The firm flagged differentiation versus adjacent NLRP3 programs and expects…
Stifel initiated coverage of Alumis Inc. (NASDAQ: ALMS) with a Buy rating and a $44.00 price target, pointing to next-generation TYK2 inhibition and encouraging topline psoriasis data for envudeucitinib as central to its bullish view. The company recently closed an upsized offering raising about $345.1 million and is planning a New Drug Application…
Stifel has initiated coverage of Equillium Inc. (NASDAQ: EQ) with a buy rating and a $5.00 price target, highlighting the company’s EQ504 candidate for inflammatory bowel disease. The stock trades near $1.92, which the analyst views as offering significant upside to the target, while third-party valuation data signals the shares may be overvalued r…
First Solar said it now expects full-year 2026 net sales well below analyst estimates after warning that additional tariffs and resulting higher module prices will dampen demand. The company's stock plunged roughly 14% in after-hours trading despite year-over-year growth in quarterly net sales and higher per-share earnings.
Jefferies raised its price target on Ferguson Plc. to $300 from $289 and kept a Buy rating, citing a constructive outlook for mergers and acquisitions. Ferguson reiterated its multi-year goals for organic growth, margin expansion and EPS growth, while management highlighted structural tailwinds and a substantial opportunity in large capital project…
A range of publicly traded companies saw notable after-hours stock moves following quarterly results and guidance. HP Inc. slid despite revenue growth, while CAVA and Trex gained on revenue beats. Workday and First Solar tumbled on forecasts that fell short of market expectations. Other companies reported mixed outcomes for earnings and revenue, co…
Duke Energy Executive Vice President and Chief Financial Officer Brian D. Savoy sold a combined $1,532,319 of common stock on February 23, 2026, and additionally disposed of shares the prior day to cover tax obligations related to vested restricted stock. The transactions coincide with the utility trading near its 52-week high and follow fourth-qua…
PayPal shares climbed for a second session after reports indicated Stripe has shown interest in acquiring all or portions of the company. Analysts outlined valuations for PayPal assets and argued why Stripe might pursue Braintree and Venmo, while noting scale and consumer reach considerations. The market reaction follows an initial surge after take…
